NCCTG phase II trial of bevacizumab in combination with sorafenib (BEV/SOR) in recurrent glioblastoma (RGBM).
- Citation:
- Neuro-oncology vol 13 (3) 62 Abstract NO-93
- Meeting Instance:
- SNO 2011
- Year:
- 2011
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 1040
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- E. Galanis S. K. Anderson J. M. Lafky T. J. Kaufmann J. H. Uhm C. Giannini S. K. Kumar D. W. Northfelt P. J. Flynn K. A. Jaeckle J. C. Buckner
- Networks:
- Study
- NCCTG-N0776
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords: